S100A10 Promotes Pancreatic Ductal Adenocarcinoma Cells Proliferation, Migration and Adhesion through JNK/LAMB3-LAMC2 Axis

SIMPLE SUMMARY: Despite the advance in therapeutic strategy, the prognosis of pancreatic ductal adenocarcinoma (PDAC) is still unsatisfactory, with a 5-year survival rate of less than 9%. As a member of the S100 protein family, S100A10 has been identified as an oncogene in multiple cancers. In PDAC,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hai, Yang, Pengfei, Li, Bixiang, Chang, Yue, Chen, Yutong, Li, Yaning, Liu, Kecheng, Liang, Xinyue, Chen, Tianliang, Dai, Yalan, Pang, Wenzheng, Zeng, Linjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818352/
https://www.ncbi.nlm.nih.gov/pubmed/36612197
http://dx.doi.org/10.3390/cancers15010202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818352/
https://www.ncbi.nlm.nih.gov/pubmed/36612197
http://dx.doi.org/10.3390/cancers15010202

Ejemplares similares